Source: Eur Respir J, 51 (6) 1800806; 10.1183/13993003.00806-2018
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Fabrizio Ricci, Per Wollmer, Gunnar Engström, Artur Fedorowski, Viktor Hamrefors. Dysregulation of the “inflammatory reflex” with abnormal neurohumoral activation may contribute to proinflammatory activity driving the progression of COPD. Eur Respir J, 51 (6) 1800806; 10.1183/13993003.00806-2018

Member's Comments

No comment yet.

Related content which might interest you: Impaired lung function is associated with systemic inflammation and macrophage activation Source: Eur Respir J 2015; 45: 557-559 Year: 2015 Adrenergic regulation of the lung inflammatory response Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases Year: 2008 The proinflammatory cytokine is important in determining the severity of asthma enhancing the inflammatory process Source: Eur Respir J 2004; 24: Suppl. 48, 592s Year: 2004 Nlrc5 is involved in allergic airway inflammation and negatively regulates inflammatory signaling pathway via TLR2/NF-?B. Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases Year: 2018 WNT-4 regulates pro-inflammatory responses driven by epithelial-mesenchymal cross-talk Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action Year: 2016 Gut microbial modulation attenuates emphysema development by suppressing inflammation and apoptosis Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD Year: 2020 Breathing disorders and survival during inflammation associated with severely hypoxia depends from prostaglandin-mediated pathway. Source: International Congress 2018 – Preclinical and clinical studies of critical illness Year: 2018 A major inflammatory cytokine TNF-a inhibits the ventilatory response to hypoxia Source: International Congress 2018 – Triggers of acute lung injury: mechanical ventilation and oxygen levels Year: 2018 Amifostine reduces lipopolysaccharide-induced lung dysfunction via suppression of redox-sensitive inflammatory signaling Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies Year: 2008 Activation of proteolytic mechanisms in response to inflammatory stimuli: a possible role in the development of the aleolocapillary barrier damage Source: Eur Respir J 2003; 22: Suppl. 45, 458s Year: 2003 The role of pro-inflammatory cytokine activation in perioperative lung injury Source: Annual Congress 2004 - Mechanisms and biomarkers of ischaemia-reperfusion-induced lung injury: lessons learnt from lung transplantation Year: 2004 Decreased PTEN amplifies PI3K signaling and enhances pro-inflammatory cytokine release in COPD Source: International Congress 2016 – Studies in airway cell biology Year: 2016 Dynamic of proinflammatory cytokines system and nonspecific markers of inflammation in patients with COPD before and after treatment with broncholitics Source: Eur Respir J 2006; 28: Suppl. 50, 38s Year: 2006 Antifibrotics modulate B lymphocyte activation resulting in a decrease of the profibrotic milieu in patients with pulmonary fibrosis Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia Year: 2019 iNOS inhibition modulates lung tissue inflammation via oxidative stress pathway activation Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD Year: 2008 Role of cytokines in regulation of inflammatory and protective reactions in progression of pulmonary MDR tuberculosis Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care Year: 2007 Circulating MDSC modulate IPF progression by orchestrating immunosuppressive and pro-fibrotic networks Source: International Congress 2018 – Advanced profiling of immune cells in chronic lung diseases Year: 2018 IL-33 blockade impacts mediators of persistence and exacerbation of chronic airway inflammation. Source: International Congress 2018 – Novel drug targets for asthma and COPD Year: 2018 ET-1 regulates pathological cell proliferation by ERK1/2 in a state of chronic inflammation Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease Year: 2010 Micro-RNA-125a/b target A20 and MAVS to promote inflammatory and impair antiviral responses in chronic obstructive pulmonary disease Source: International Congress 2016 – Mechanisms of disease Year: 2016